Every earnings call for VINATIORGA — management tone, guidance, KPIs and promise tracking, quarter by quarter.
VINATIORGA · 5 transcripts · Chemicals · latest Q4 FY25Revenue ₹2,292 cr (+18% YoY); EBITDA ₹625 cr (+23% YoY); EBITDA Margin 27.2%. Consolidated Revenue for FY25 grew 18% YoY to ₹2,292 crores, driven by strong volume growth in ATBS and Antioxidants.
Read full transcript & analysisRevenue ₹534 cr (+19% YoY); PAT ₹86 cr (+24% YoY). Net income grew 19% YoY to ₹533.98 crores, driven by robust demand in the ATBS segment.
Read full transcript & analysisFY24 Revenue ₹1,930 cr (−9% YoY); EBITDA ₹160 cr; PAT ₹104 cr. Q4 FY24 Revenue reached ₹560 crores, a sequential increase of 23% from Q3 FY24.
Read full transcript & analysisRevenue ₹457 cr; EBITDA ₹124 cr; EBITDA Margin 27%. Total Income for Q3 FY24 stood at ₹457 crores on a merged basis, a 4% decline QoQ.
Read full transcript & analysisRevenue ₹430 cr (−14% YoY); EBITDA ₹109 cr (−16% YoY); EBITDA Margin 28%. Revenue from operations stood at ₹430 crores, a 14% decline from ₹500 crores in Q1 FY23.
Read full transcript & analysis